vimarsana.com

Page 62 - நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CoinShares International Limited: Formal approval of CoinShares listing application and first day of trading on Nasdaq First North Growth Market

CoinShares International Limited: Formal approval of CoinShares listing application and first day of trading on Nasdaq First North Growth Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Nasdaq Stockholm AB: ChromoGenics AB (publ) receives observation status (93/21)

Nasdaq Stockholm AB: ChromoGenics AB (publ) receives observation status (93/21) On March 3, 2021, TopRight Nordic Aktiebolag (publ) disclosed a public takeover offer to the holders of shares and warrantsin ChromoGenics AB (publ). The rules of Nasdaq First North Growth Market state that a listed company may be given observation status if the company is subject to a public takeover offer. With reference to the above, Nasdaq Stockholm AB decides that the shares (CHRO, ISIN code SE0014730719, order book ID 135174) and the warrants (CHRO TO3, ISIN code SE0015195367, order book ID 213442) in ChromoGenics AB (publ) shall be given observation status. For further information about this exchange notice, please contact Issuer

Investegate |CoinShares International Limit Announcements | CoinShares International Limit: Formal approval of CoinShares listing application and first day of trading on Nasdaq First North Growth Market

Nanoform Finland Plc: 5 633 803 new shares registered with the trade register

Nanoform Finland Plc: 5 633 803 new shares registered with the trade register Nanoform Company Announcement Nanoform Finland Plc: 5 633 803 new shares registered with the trade register NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Nanoform Finland Plc ( Nanoform or the Company ), an innovative nanoparticle medicine enabling company, announced on March 9, 2021 the result of the offering of new shares (the Shares ) in an accelerated bookbuilding directed to institutional and other qualified investors (the

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.